表紙
市場調查報告書

敗血症診斷:各化驗技術趨勢、預測 (2020-2024年)

Sepsis Diagnostics Global Markets by Assay Technology with Executive and Consultant Guides. Including Customized Forecasting and Analysis 2020 to 2024

出版商 Howe Sound Research 商品編碼 928146
出版日期 內容資訊 英文 248 Pages
商品交期: 最快1-2個工作天內
價格
敗血症診斷:各化驗技術趨勢、預測 (2020-2024年) Sepsis Diagnostics Global Markets by Assay Technology with Executive and Consultant Guides. Including Customized Forecasting and Analysis 2020 to 2024
出版日期: 2020年03月08日內容資訊: 英文 248 Pages
簡介

敗血症沒有確定性的診斷法,年度的死者超過3000萬名。對於過去10年抬頭的基因及分子診斷工具的診斷法的確立,競爭開始。

本報告提供敗血症診斷的市場調查,彙整敗血症概要,市場結構、進入經營者,市場成長的主要影響因素分析,企業間的各種展開,技術開發趨勢,主要企業的簡介,化驗類型、產品類型、各主要國家的市場規模的預測等資料。

第1章 簡介、市場定義

第2章 敗血症:現狀

  • 所謂敗血症
  • 診斷
    • 感染疾病鑑定
    • 生物標記
    • 鑑別診斷
  • 敗血症的原因
  • 盛行率

第3章 產業概要

  • 進入經營者、機關

第4章 市場趨勢

  • 成長推動因素
  • 阻礙成長要素
  • 診斷技術的開發

第5章 敗血症診斷:近幾年的發展

  • NGS技術提供敗血症的迅速且正確的診斷
  • 可攜式設備造成快速的診斷
  • Ontera、QuantuMDx:在敗血症診斷上聯合
  • 血液檢驗正確預測敗血症的重病度
  • HHS:推動Cytovale迅速檢驗的開發
  • Mologic:開發使用了多標記的敗血症檢驗
  • Abionic:表現5分種的敗血症診斷的確證成果
  • T2 Biosystems:迅速診斷技術的新資料、更新
  • 敗血症:判明適合4個亞型
  • GenMark Diagnostics:用血液面板取得FDA許可
  • Novacyt、Immunexpress:延長敗血症化驗開發的聯盟等

第6章 主要企業的簡介

  • Abbott Diagnostics
  • Abionic
  • Accel Diagnostics
  • Accelerate Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Biocartis
  • bioMerieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Bruker
  • Cube Dx
  • Curetis N.V. / Curetis GmbH
  • Cytovale
  • EKF Diagnostics Holdings
  • GeneFluidics
  • GenMark Dx
  • Grifols
  • Immunexpress
  • Inflammatix
  • Linear Diagnostics
  • Luminex Corp
  • Mbio Diagnostics
  • Mobidiag
  • Nanomix
  • Qiagen Gmbh
  • Response Biomedical
  • Roche Molecular Diagnostics
  • SeLux Diagnostics
  • Septec
  • Siemens Healthineers
  • Sphingotec
  • T2 Biosystems
  • Thermo Fisher Scientific Inc

第7章 敗血症診斷市場:各國

第8章 敗血症診斷市場:各種類型

  • 各診斷類型、化驗類型
  • 微生物化驗
  • 症候群PoC面板
  • 其他感染疾病
  • 生物標記分子診斷
  • 生物標記 (其他)

第9章 敗血症診斷市場:各產品類型

  • 設備
  • 試劑
  • 軟體&服務

附錄

目錄

OVERVIEW:

Sepsis is killing over 30 million people a year with no definitive diagnostic in hand. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life saving diagnostics can command a premium in the market. Understand what is driving this huge global diagnostic market and where the opportunity lies.

Our facts and support = Your success.

The report forecasts the market size out to 2024. Growth is coming from the basic factors but technology and education are creating the awareness needed to rapidly expand the diagnostic market. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnositic and the Genomics Revolution are merging to create new diagnostic opportunities.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

  • i. Market Guides
    • iA. Situation Analysis
    • iB. Guide for Executives and Marketing Staff
    • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1 An Overview of Sepsis Diagnostics
    • 1.1.1 Sepsis the medical emergency
    • 1.1.2 Sepsis Diagnosis and Comorbidity
  • 1.3 Market Definition
    • 1.3.1 Market Size
    • 1.3.2 Currency
    • 1.3.3 Years
    • 1.3.4 Microbiology
    • 1.3.5 Other Infectious Disease
    • 1.3.6 Syndromic PoC
    • 1.3.7 Biomarkers Molecular Diagnostics
    • 1.3.8 Biomarkers Other
    • 1.3.9 Limitations
  • 1.4 Methodology
    • 1.4.1 Authors
    • 1.4.2 Sources
  • 1.5 U.S. Medical Market and laboratory Testing - Perspective
    • 1.4.1 U.S. Medicare Expenditures for Laboratory Testing

2. Sepsis - Current Science

  • 2.1 What is Sepsis?
    • 2.1.1 Organ Damage
    • 2.1.2 Neonatal sepsis
    • 2.1.3 Prognosis
  • 2.2 Diagnosis
    • 2.2.1 Infection Identification
    • 2.2.2 Biomarkers
    • 2.2.3 Differential diagnosis
  • 2.3 Causes of Sepsis
    • 2.3.1 Sepsis Progression
  • 2.4 Prevalence

3. Industry Overview

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Diagnostic Test Developer
    • 3.1.3 Pharmaceutical/Reagent Supplier
    • 3.1.4 Independent Testing Lab
    • 3.1.6 Public National/regional lab
    • 3.1.7 Hospital lab
    • 3.1.8 Physician Lab
    • 3.1.9 Audit Body
    • 3.1.10 Certification Body

4. Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Increasing Prevalence
    • 4.1.2 Antimicrobial Resistance
    • 4.1.3 Increasing Diagnosis
    • 4.1.4 Multiplex Diagnostics Impacts
    • 4.1.5 The Aging World
    • 4.1.6 Developing World Health Care Spending
  • 4.2 Factors Limiting Growth
    • 4.2.1 The Cost Curve Shrinks the Market
    • 4.2.2 The Diagnostics Dillemma
    • 4.2.3 Adoption Lag and Cost Control
  • 4.3 Diagnostic Technology Development
    • 4.3.1 The Multiplex Opportunity
    • 4.3.2 Shifting Role of Physicians in Diagnosis
    • 4.3.3 Diagnostics Moves Out of the Lab
    • 4.3.4 Biomarkers and Algorithms
    • 4.3.5 Rapid Testing Changing Medical Practice
    • 4.3.6 Genome Role and Big Data
    • 4.3.6 The Next Five Years

5. Sepsis Diagnostics - Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
      • NGS technique offers quick, accurate diagnosis of sepsis
      • Portable device diagnoses sepsis faster
      • Ontera and QuantuMDx Collaborate to Advance Sepsis Diagnosis
      • Blood Test Accurately Predicts Sepsis Severity
      • Sepsis diagnostics: HHS to advance development of Cytovale rapid test
      • Mologic Developing Sepsis Test Using Multimarker
      • Abionic: Study Demonstrates Diagnosis of Sepsis in 5 Minutes
      • T2 Biosystems Introduces New Data and Updates for Rapid Diagnostic Technology
      • Sepsis found to fit into 4 subtypes
      • GenMark Diagnostics Receives FDA Clearance for Blood Panel
      • Novacyt, Immunexpress Extend Sepsis Assay Development Partnership
      • New Test Could Diagnose Sepsis Faster
      • Immunexpress Wins $745K HHS Contract for Rapid Sepsis Assay
      • Curetis' Unyvero Application Cartridges Receive Regulatory Approvals
      • Luminex to Pay $75M for MilliporeSigma's Flow Cytometry Research Portfolio
      • Experimental 2.5-minute Sepsis Test Discovered
      • sphingotec raises €20 million
      • SeLux Diagnostics Announces Sepsi U.S. HHS/BARDA Research Funding
      • Roche PCT assay cleared as tool in fight against Sepsis
      • GeneFluidics selected as finalist for AMR Challenge
      • BioDirection, Inc. Announces System to Diagnose and Monitor Sepsis
      • sphingotec Adding Advanced POC Testing Platform
      • Rapid Detection Using DNAe's LiDia® Bloodstream Infection Technology
      • Septec Team Working on 15 Minute Sepsis Diagnosis
      • Abionic Announces Rapid Sepsis PoC Diagnostic

6. Profiles of Key Companies

  • Abbott Diagnostics
  • Abionic
  • Accel Diagnostics
  • Accelerate Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Biocartis
  • bioMérieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Bruker
  • Cube Dx
  • Curetis N.V. / Curetis GmbH
  • Cytovale
  • EKF Diagnostics Holdings
  • GeneFluidics
  • GenMark Dx
  • Grifols
  • Immunexpress
  • Inflammatix
  • Linear Diagnostics
  • Luminex Corp
  • Mbio Diagnostics
  • Mobidiag
  • Nanomix
  • Qiagen Gmbh
  • Response Biomedical
  • Roche Molecular Diagnostics
  • SeLux Diagnostics
  • Septec
  • Siemens Healthineers
  • Sphingotec
  • T2 Biosystems
  • Thermo Fisher Scientific Inc

7. Sepsis Diagnostic Markets

  • 7.1 Sepsis Diagnostics - Global Market Overview by Country
    • 7.1.1 Table - Global Market by Country
    • 7.1.2 Chart - Global Market by Country

8. Global Sepsis Diagnostics Markets - By Assay Type

  • 8.1 Global Market by Diagnostic Type - Overview
    • 8.1.1 Table - Global Market by Diagnostic Type
    • 8.1.2 Chart - Global Market by Assay Type
    • 8.1.3 Chart - Global Market by Type - 2019
    • 8.1.4 Chart - Global Market by Type -2024
    • 8.1.4 Chart - Global Market by Type - Share by Year
  • 8.2 Sepsis Diagnostic - Microbiology
    • 8.2.1 Table Sepsis Diagnostic Microbiology - by Country
    • 8.2.2 Chart - Sepsis Diagnostic Microbiology Growth
  • 8.3 Sepsis Diagnostic - Syndromic PoC Panel
    • 8.3.1 Table Sepsis Diagnostic Syndromic PoC Panel - by Country
    • 8.3.2 Chart - Sepsis Diagnostic Syndromic PoC Panel Growth
  • 8.4 Sepsis Diagnostic - Other Infectious Disease
    • 8.4.1 Table Sepsis Diagnostic Other ID - by Country
    • 8.4.2 Chart - Sepsis Diagnostic - Other Infectious Disease Growth
  • 8.5 Sepsis Diagnostic - Biomarker Molecular Diagnostic
    • 8.5.1 Table Sepsis Diagnostic Biomarker MDx - by Country
    • 8.5.2 Chart - Sepsis Diagnostic - Biomarker MDx Growth
  • 8.6 Sepsis Diagnostic - Biomarker Other
    • 8.6.1 Table Sepsis Diagnostic Biomarker Other - by Country
    • 8.6.2 Chart - Sepsis Diagnostic - Biomarker Other Growth

9. Global Sepsis Diagnostics Markets - By Product Type

  • 9.1 Global Market by Product Type - Overview
    • 9.1.1 Table - Global Market by Product Type
    • 9.1.2 Chart - Global Market by Product Type - 2019/2024 Comparison
    • 9.1.3 Chart - Global Market by Product Type - Base Year
    • 9.1.4 Chart - Global Market by Product Type - Final Year
    • 9.1.4 Chart - Global Market by Product Type - Share by Year
  • 9.2 Sepsis Diagnostic - Instruments
    • 9.2.1 Table Sepsis Diagnostic Instruments - by Country
    • 9.2.2 Chart - Sepsis Diagnostic Instruments Growth
  • 9.3 Sepsis Diagnostic - Reagents
    • 9.3.1 Table Sepsis Diagnostic Reagents - by Country
    • 9.3.2 Chart - Sepsis Diagnostic Reagents Growth
  • 9.4 Sepsis Diagnostic - Software & Service
    • 9.4.1 Table Sepsis Diagnostic SW & Service - by Country
    • 9.4.2 Chart - Sepsis Diagnostic - SW & Services Growth

Appendices

  • I. United States Medicare System: 2019 Clinical Laboratory Fees Schedule - National Limit and Midpoint

Table of Tables

  • Table 1 Lab Spending 2014 to 2024
  • Table 2 sepsis biomarkers - Established and potential
  • Table 3 Market Players by Type
  • Table 4 Five Factors Driving Growth
  • Table 5 Three Factors Limiting Growth
  • TABLE 6 - GLOBAL SEPSIS DIAGNOSTICS MARKET BY COUNTRY/REGION
  • TABLE 7 GLOBAL MARKET BY ASSAY TYPE
  • TABLE 8 SEPSIS DIAGNOSTIC MICROBIOLOGY BY COUNTRY
  • TABLE 9 SEPSIS DIAGNOSTIC SYNDROMIC POC PANEL BY COUNTRY
  • TABLE 10 SEPSIS DIAGNOSTIC OTHER ID BY COUNTRY
  • TABLE 11 SEPSIS DIAGNOSTIC BIOMARKER MDX BY COUNTRY
  • TABLE 12 SEPSIS DIAGNOSTIC BIOMARKER OTHER BY COUNTRY
  • TABLE 13 GLOBAL MARKET BY PRODUCT TYPE
  • TABLE 14 SEPSIS DIAGNOSTIC INSTRUMENTS BY COUNTRY
  • TABLE 15 SEPSIS DIAGNOSTIC REAGENTS BY COUNTRY
  • TABLE 16 SEPSIS DIAGNOSTIC SW & SERV BY COUNTRY
  • Table 17 2019 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1 Sepsis Survival graph
  • Figure 2 Percentage of Sepsis Patients with Comorbidity
  • Figure 3 Clinical Lab Spending 2014 to 2024
  • Figure 4 Sepsis Clinical Progression
  • Figure 5 Deaths From Drug Resistant Infections 2050
  • Figure 6 Aggregate Age of World Population
  • Figure 7 Growth in Health Care Spending Developing World
  • Figure 8 Comparing The New Diagnostics and Traditional Testing
  • Figure 9 Growth rates of Sepsis Diagnostics
  • Figure 10 Global Market Density Chart
  • Figure 11 Sepsis Diagnostics Market by Type - 2019 vs. 2024
  • FIGURE 12 SEPSIS DIAGNOSTICS MARKET 2019
  • FIGURE 13 SEPSIS DIAGNOSTICS MARKET 2024
  • FIGURE 14 TYPE SHARE BY YEAR
  • FIGURE 15 SEPSIS DIAGNOSTIC MICROBIOLOGY GROWTH
  • FIGURE 16 SEPSIS DIAGNOSTICS SYNDROMIC POC PANEL GROWTH
  • FIGURE 17 SEPSIS DIAGNOSTIC OTHER INFECTIOUS DISEASE GROWTH
  • FIGURE 18 SEPSIS DIAGNOSTIC MOLECULAR DIAGNOSTICS GROWTH
  • FIGURE 19 SEPSIS DIAGNOSTIC BIOMARKER OTHER GROWTH
  • Figure 20 Sepsis Diagnostics Market by Product Type - 2019 vs. 2024
  • FIGURE 21 SEPSIS DIAGNOSTICS MARKET BY PRODUCT TYPE BASE YEAR
  • FIGURE 22 SEPSIS DIAGNOSTICS MARKET BY PRODUCT TYPE FINAL YEAR
  • FIGURE 23 PRODUCT TYPE SHARE BY YEAR
  • FIGURE 24 SEPSIS DIAGNOSTIC INSTRUMENTS GROWTH
  • FIGURE 25 SEPSIS DIAGNOSTICS HBA1C GROWTH
  • FIGURE 26 SEPSIS DIAGNOSTIC SE & SERVICES GROWTH